Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Heron Therapeutics Cash on Hand 2010-2025 | HRTX

Heron Therapeutics cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
Heron Therapeutics Annual Cash on Hand
(Millions of US $)
2024 $59
2023 $80
2022 $85
2021 $158
2020 $208
2019 $391
2018 $332
2017 $172
2016 $51
2015 $131
2014 $73
2013 $72
2012 $54
2011 $18
2010 $2
2009 $8
Heron Therapeutics Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $51
2024-12-31 $59
2024-09-30 $71
2024-06-30 $67
2024-03-31 $72
2023-12-31 $80
2023-09-30 $77
2023-06-30 $33
2023-03-31 $60
2022-12-31 $85
2022-09-30 $122
2022-06-30 $84
2022-03-31 $112
2021-12-31 $158
2021-09-30 $203
2021-06-30 $258
2021-03-31 $166
2020-12-31 $208
2020-09-30 $258
2020-06-30 $301
2020-03-31 $356
2019-12-31 $391
2019-09-30 $256
2019-06-30 $276
2019-03-31 $289
2018-12-31 $332
2018-09-30 $365
2018-06-30 $423
2018-03-31 $114
2017-12-31 $172
2017-09-30 $74
2017-06-30 $109
2017-03-31 $165
2016-12-31 $51
2016-09-30 $89
2016-06-30 $75
2016-03-31 $100
2015-12-31 $131
2015-09-30 $153
2015-06-30 $172
2015-03-31 $56
2014-12-31 $73
2014-09-30 $86
2014-06-30 $105
2014-03-31 $57
2013-12-31 $72
2013-09-30 $23
2013-06-30 $35
2013-03-31 $46
2012-12-31 $54
2012-09-30 $60
2012-06-30 $12
2012-03-31 $13
2011-12-31 $18
2011-09-30 $21
2011-06-30 $21
2011-03-31 $1
2010-12-31 $2
2010-09-30 $3
2010-06-30 $6
2010-03-31 $8
2009-12-31 $8
2009-09-30 $2
2009-06-30 $4
2009-03-31 $7
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.294B $0.144B
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.271B 31.99
Zoetis (ZTS) United States $73.161B 27.30
Takeda Pharmaceutical (TAK) Japan $48.365B 9.62
Daiichi Sankyo, - (DSNKY) Japan $46.601B 23.88
BeOne Medicines - (ONC) Cayman Islands $29.540B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.150B 0.00
Merck (MKKGY) Germany $17.047B 12.49
Summit Therapeutics (SMMT) United States $14.690B 0.00
Shionogi (SGIOY) Japan $14.547B 0.00
United Therapeutics (UTHR) United States $12.781B 11.31
Neurocrine Biosciences (NBIX) United States $12.310B 42.17
Orion OYJ (ORINY) Finland $10.212B 27.62
IPSEN (IPSEY) France $10.004B 0.00
Corcept Therapeutics (CORT) United States $7.429B 60.40
Stevanato Group S.p.A (STVN) Italy $7.111B 43.48
Madrigal Pharmaceuticals (MDGL) United States $6.563B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.664B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.989B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.975B 0.00
Hypermarcas (HYPMY) Brazil $2.939B 19.33
Catalyst Pharmaceuticals (CPRX) United States $2.870B 10.06
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.429B 13.14
NewAmsterdam Pharma (NAMS) Netherlands $2.269B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.000B 0.00
Indivior (INDV) United States $1.915B 8.12
Centessa Pharmaceuticals (CNTA) United Kingdom $1.653B 0.00
Dyne Therapeutics (DYN) United States $1.638B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.512B 0.00
Ocular Therapeutix (OCUL) United States $1.391B 0.00
Guardian Pharmacy Services (GRDN) United States $1.246B 0.00
Harrow (HROW) United States $1.112B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.105B 22.11
Enliven Therapeutics (ELVN) United States $1.075B 0.00
Collegium Pharmaceutical (COLL) United States $0.938B 5.06
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.926B 0.00
Ardelyx (ARDX) United States $0.861B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Elite Pharmaceuticals (ELTP) United States $0.718B 0.00
Xeris Biopharma Holdings (XERS) United States $0.680B 0.00
Xencor (XNCR) United States $0.654B 0.00
KalVista Pharmaceuticals (KALV) United States $0.644B 0.00
AleAnna (ANNA) United States $0.592B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Altimmune (ALT) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.552B 0.00
USANA Health Sciences (USNA) United States $0.550B 11.96
Verve Therapeutics (VERV) United States $0.549B 0.00
Bioventus (BVS) United States $0.544B 13.79
Theravance Biopharma (TBPH) United States $0.535B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.499B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
Oruka Therapeutics (ORKA) United States $0.470B 0.00
Siga Technologies (SIGA) United States $0.454B 9.49
Organogenesis (ORGO) United States $0.389B 0.00
Savara (SVRA) United States $0.382B 0.00
Liminatus Pharma (LIMN) United States $0.375B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.367B 9.91
Aquestive Therapeutics (AQST) United States $0.340B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.44
Nanobiotix S.A (NBTX) France $0.252B 0.00
ProKidney (PROK) United States $0.245B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.235B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
MediWound (MDWD) Israel $0.221B 0.00
OmniAb (OABI) United States $0.217B 0.00
4D Molecular Therapeutics (FDMT) United States $0.203B 0.00
Profound Medical (PROF) Canada $0.197B 0.00
Larimar Therapeutics (LRMR) United States $0.184B 0.00
Aldeyra Therapeutics (ALDX) United States $0.167B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Journey Medical (DERM) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.146B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Achieve Life Sciences (ACHV) Canada $0.113B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Champions Oncology (CSBR) United States $0.106B 17.41
Fractyl Health (GUTS) United States $0.101B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.100B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Wellgistics Health (WGRX) United States $0.096B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
Surrozen (SRZN) United States $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 58.22
Inotiv (NOTV) United States $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
ESSA Pharma (EPIX) Canada $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.054B 0.00
Metagenomi (MGX) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Klotho Neurosciences (KLTO) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
FibroGen (FGEN) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00